Meeting of the Board of Scientific Counselors Infectious Diseases, 75542 [2024-20944]

Download as PDF 75542 Federal Register / Vol. 89, No. 179 / Monday, September 16, 2024 / Notices summary ratings to ensure the ratings are consistent with established performance requirements, reflect meaningful distinctions among senior executives based on their relative performance and organizational results and provide recommendations for ratings, awards, and pay adjustments in a fair and equitable manner: Thomas Brandt, Jim Courtney, Kim Weaver, and Trevor Williams. Dharmesh Vashee, General Counsel, Federal Retirement Thrift Investment Board. BILLING CODE 6760–01–P FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Notice of Board Meeting September 24, 2024 at 10 a.m. EDT. Telephonic. Dial-in (listen only) information: Number: 1–202–599– 1426, Code: 884 634 853 #; or via web: https://www.frtib.gov/. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. SUPPLEMENTARY INFORMATION: Board Meeting Agenda Open Session 1. Approval of the August 27, 2024, Board Meeting Minutes 2. Investment Manager Annual Service Review 3. Monthly Reports (a) Participant Report (b) Investment Report (c) Legislative Report 4. Quarterly Reports (d) Vendor Risk Management 5. Mid-Year Financial Review 6. Participant Satisfaction Survey Closed Session 7. Information covered under 5 U.S.C. 552b (c)(9)(B) and (c)(10). lotter on DSK11XQN23PROD with NOTICES1 Authority: 5 U.S.C. 552b (e)(1). Dated: September 11, 2024. Dharmesh Vashee, General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2024–20952 Filed 9–13–24; 8:45 am] BILLING CODE 6760–01–P VerDate Sep<11>2014 17:23 Sep 13, 2024 Jkt 262001 Centers for Disease Control and Prevention Meeting of the Board of Scientific Counselors Infectious Diseases Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Board of Scientific Counselors Infectious Diseases (BSC ID). This virtual meeting is open to the public via Zoom, limited only by the number of web conference lines available (500 lines). Registration in advance is required by accessing the link below in the addresses section. Time will be available for public comment. DATES: The meeting will be held on November 4 and 5, 2024, from 11 a.m. to 5 p.m., EST. ADDRESSES: Zoom virtual meeting. Registration in advance is required by accessing the link at https:// cdc.zoomgov.com/webinar/register/WN_ fHWh_7peSgyUTYagidwsmg. Instructions to access the meeting will be provided following registration. FOR FURTHER INFORMATION CONTACT: Sarah Wiley, M.P.H., Senior Advisor, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16–5, Atlanta, Georgia 30329–4027. Telephone: (404) 639–4840; Email: SWiley@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board of Scientific Counselors Infectious Diseases (BSC ID) provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, Centers for Disease Control and Prevention (CDC); and the Directors of the National Center for Emerging and Zoonotic Infectious Diseases, the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, the National Center for Immunization and Respiratory Diseases, and the Global Health Center, CDC, concerning strategies, goals, and priorities for the programs and research within the national centers and monitors the overall strategic direction and focus of CDC’s infectious disease programs and centers. Matters to be Considered: The agenda will include updates from and SUMMARY: [FR Doc. 2024–21003 Filed 9–13–24; 8:45 am] DATES: DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 discussions of programmatic priorities of CDC’s national centers that address infectious diseases and will include reports from each of the Board’s workgroups. Agenda items are subject to change as priorities dictate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–20944 Filed 9–13–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Sexual Risk Avoidance Education Program Performance Analysis Study—Extension (Office of Management and Budget (OMB) #0970–0536) Office of Planning, Research, and Evaluation, Administration for Children and Families, Department of Health and Human Services. ACTION: Request for public comments. AGENCY: The Office of Planning, Research, and Evaluation (OPRE) and the Family and Youth Services Bureau in the Administration for Children and Families (ACF) request an extension without changes of a currently approved information collection activity as part of the Sexual Risk Avoidance Education (SRAE) Program Performance Analysis Study (PAS). The goal of the study is to collect, analyze, and report on performance measures data for the SRAE program (OMB Control No. 0970– 0536; expiration date 1/31/2025). The purpose of the requested extension is to continue the ongoing data collection and submission of the performance measures by SRAE grant recipients. DATES: Comments due November 15, 2024. In compliance with the requirements of the Paperwork Reduction Act of 1995, ACF is soliciting public comment on the specific aspects SUMMARY: E:\FR\FM\16SEN1.SGM 16SEN1

Agencies

[Federal Register Volume 89, Number 179 (Monday, September 16, 2024)]
[Notices]
[Page 75542]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20944]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Board of Scientific Counselors Infectious Diseases

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Board of Scientific Counselors Infectious 
Diseases (BSC ID). This virtual meeting is open to the public via Zoom, 
limited only by the number of web conference lines available (500 
lines). Registration in advance is required by accessing the link below 
in the addresses section. Time will be available for public comment.

DATES: The meeting will be held on November 4 and 5, 2024, from 11 a.m. 
to 5 p.m., EST.

ADDRESSES: Zoom virtual meeting. Registration in advance is required by 
accessing the link at https://cdc.zoomgov.com/webinar/register/WN_fHWh_7peSgyUTYagidwsmg. Instructions to access the meeting will be 
provided following registration.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, M.P.H., Senior Advisor, 
National Center for Emerging and Zoonotic Infectious Diseases, Centers 
for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16-
5, Atlanta, Georgia 30329-4027. Telephone: (404) 639-4840; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board of Scientific Counselors Infectious Diseases 
(BSC ID) provides advice and guidance to the Secretary, Department of 
Health and Human Services; the Director, Centers for Disease Control 
and Prevention (CDC); and the Directors of the National Center for 
Emerging and Zoonotic Infectious Diseases, the National Center for HIV, 
Viral Hepatitis, STD, and TB Prevention, the National Center for 
Immunization and Respiratory Diseases, and the Global Health Center, 
CDC, concerning strategies, goals, and priorities for the programs and 
research within the national centers and monitors the overall strategic 
direction and focus of CDC's infectious disease programs and centers.
    Matters to be Considered: The agenda will include updates from and 
discussions of programmatic priorities of CDC's national centers that 
address infectious diseases and will include reports from each of the 
Board's workgroups. Agenda items are subject to change as priorities 
dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-20944 Filed 9-13-24; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.